Marshall Wace’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Marshall Wace’s Portfolio OMIC Stock Details OMIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-582	Closed	-$111K	–	3970
2022 Q1	$111K	Sell	582 -1,666	-74%	-$385K	﹤0.01%	3185
2021 Q4	$780K	Sell	2,248 -13,484	-86%	-$5.23M	﹤0.01%	2597
2021 Q3	$5.28M	Sell	15,732 -912	-5%	-$468K	0.02%	907
2021 Q2	$13.7M	Buy	+16,644	New	+$12.9M	0.06%	342

Other funds holding OMIC

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCM

Revelation Capital Management Sausalito, California $67.4M AUM

Tikvah Management Charlotte, North Carolina $323M AUM 69.61% 1-Year Est. Return

Marshall Wace's OMIC Position: Q2 2022 in Review

Marshall Wace sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q2 2022, closing a stake of 582 shares — an estimated $111K sold.

Marshall Wace first reported a position in OMIC in Q2 2021 and held it in 4 quarters. The position peaked at $13.7M in Q2 2021. 76 funds tracked by Wall St. Rank hold OMIC as of Q2 2022.

Marshall Wace reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Marshall Wace sold 582 Singular Genomics Systems, Inc. Common Stock shares in Q2 2022, an estimated $111K.
Marshall Wace first reported a position in Singular Genomics Systems, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
Marshall Wace's Singular Genomics Systems, Inc. Common Stock position peaked at $13.7M in Q2 2021.
76 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q2 2022.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.